Showing results (111-120 of 150) with videos related to
Sort By:
Pageof 15
Cancers|November 11, 2022
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer CommitteeAlexandra Masson-Lecomte, Victoire Vaillant, Mathieu Roumiguié, et al.The French Journal of Urology|October 18, 2025
Updated 2025 French guidelines for renal cell carcinomaPierre Bigot, Zine-Eddine Khene, Romain Boissier, et al.BJU International|May 10, 2012
The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative studyAlexis Arvin Berod, Pierre Colin, David R Yates, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 TrialNadine Houédé, Thierry Chevallier, François Audenet, et al.Cell Reports|December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypesAnne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.BJU International|March 8, 2012
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre studyPierre Colin, Adil Ouzzane, Géraldine Pignot, et al.European Urology Focus|June 10, 2025
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder CancerMithun Kailavasan, Alberto Martini, Max Bruins, et al.Urologic Oncology|September 5, 2025
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)Caroline Pettenati, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.Oncogene|March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networksHélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.European Urology Focus|December 20, 2025
Digital Systematic Collection of Data for Patient-reported Outcome and Experience Measures Reveals Real-world Recovery Trajectories After Robot-assisted Radical ProstatectomyArthur Peyrottes, Charles Dariane, Laurent Brureau, et al.Pageof 15